These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7973944)

  • 41. Genetically determined variation in immune response to filarial infections.
    Wakelin D
    J Commun Dis; 1986 Dec; 18(4):234-42. PubMed ID: 3309027
    [No Abstract]   [Full Text] [Related]  

  • 42. HLA and elephantiasis in lymphatic filariasis.
    Yazdanbakhsh M; Sartono E; Kruize YC; Kurniawan A; Partono F; Maizels RM; Schreuder GM; Schipper R; de Vries RR
    Hum Immunol; 1995 Sep; 44(1):58-61. PubMed ID: 8522456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in immunology and immunopathology of lymphatic filariasis.
    Mak JW
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():76-81. PubMed ID: 7973952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can anopheline-transmitted filariasis be eradicated?
    Webber RH
    J Trop Med Hyg; 1991 Aug; 94(4):241-4. PubMed ID: 1880825
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of insecticide-treated materials on filaria transmission by the various species of vector mosquito in Africa.
    Pedersen EM; Mukoko DA
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S91-5. PubMed ID: 12625922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relationships between the percentages of microfilariae and the microfilarial density in man and that of filarial larva in the mosquito vector in a Wuchereria bancrofti endemic area].
    He SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Oct; 3(5):297-9. PubMed ID: 6136338
    [No Abstract]   [Full Text] [Related]  

  • 47. First genome-wide association study for lymphatic filariasis in a West African population points to a human leukocyte antigen-mediated disease pathophysiology.
    Grover S; Opoku VS; Debrah LB; Maj C; Osei-Mensah J; Mensah DA; Hoerauf A; Debrah AY; Schumacher J; Pfarr K
    Int J Infect Dis; 2023 Aug; 133():1-4. PubMed ID: 37146673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epidemiological study on lymphatic filariasis (Wuchereria bancrofti) in Sénégal].
    Faye O; Faye B; Ndiaye JL; Tine RC; Ndiaye D; Haydara Mbacké A
    Med Trop (Mars); 2009 Feb; 69(1):101-2. PubMed ID: 19499747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.
    Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B
    J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug targets for lymphatic filariasis: a bioinformatics approach.
    Sharma OP; Vadlamudi Y; Kota AG; Sinha VK; Kumar MS
    J Vector Borne Dis; 2013 Sep; 50(3):155-62. PubMed ID: 24220073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mattancherry urban agglomeration, a diminishing focus of lymphatic filariasis in Kerala.
    Arunachalam N; Mariappan T; Vijayakumar KN; Sabesan S; Panicker KN
    J Commun Dis; 1996 Sep; 28(3):168-70. PubMed ID: 8973015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The control of lymphatic filariasis].
    Karam M; Ottesen E
    Med Trop (Mars); 2000; 60(3):291-6. PubMed ID: 11258066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood.
    Malhotra I; Mungai PL; Wamachi AN; Tisch D; Kioko JM; Ouma JH; Muchiri E; Kazura JW; King CL
    J Infect Dis; 2006 Apr; 193(7):1005-13. PubMed ID: 16518763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission.
    Gbakima AA; Appawu MA; Dadzie S; Karikari C; Sackey SO; Baffoe-Wilmot A; Gyapong J; Scott AL
    Trop Med Int Health; 2005 Apr; 10(4):387-92. PubMed ID: 15807803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphism of gp15/400 allergen gene of Wuchereria bancrofti from different regions of India endemic for lymphatic filariasis.
    Hoti SL; Thangadurai R; Patra KP; Das PK
    Infect Genet Evol; 2007 Mar; 7(2):213-8. PubMed ID: 17056300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Animal hosts in experimental lymphatic filariasis research.
    Kumar V; Van Kerckhoven I; Pandey VS
    Ann Soc Belg Med Trop; 1991 Sep; 71(3):173-86. PubMed ID: 1958103
    [No Abstract]   [Full Text] [Related]  

  • 58. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J
    Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580
    [No Abstract]   [Full Text] [Related]  

  • 59. Mosquito vectors of bancroftian filariasis in Kwale District, Kenya.
    Mwandawiro CS; Fujimaki Y; Mitsui Y; Katsivo M
    East Afr Med J; 1997 May; 74(5):288-93. PubMed ID: 9337005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis.
    Debrah AY; Mand S; Toliat MR; Marfo-Debrekyei Y; Batsa L; Nürnberg P; Lawson B; Adjei O; Hoerauf A; Pfarr K
    Am J Trop Med Hyg; 2007 Oct; 77(4):601-8. PubMed ID: 17978056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.